Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Sarah J. Tabrizi, Carlos Estevez‐Fraga, Willeke M. C. van Roon‐Mom, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 7, pp. 645-658
Open Access | Times Cited: 203

Showing 26-50 of 203 citing articles:

Unraveling the Puzzle of Therapeutic Peptides: A Promising Frontier in Huntington’s Disease Treatment
Shakir Ahamad, Nargis Bano, Sameera Khan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 783-815
Closed Access | Times Cited: 8
The cytosolic DNA‐sensing cGAS–STING pathway in neurodegenerative diseases
Xiaofeng Guo, Lin Yang, Jiawei Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 8
New Insights into Mitochondria in Health and Diseases
Ya Li, Huhu Zhang, Chunjuan Yu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9975-9975
Open Access | Times Cited: 8
Cell therapy for neurological disorders
Soshana Svendsen, Clive N. Svendsen
Nature Medicine (2024) Vol. 30, Iss. 10, pp. 2756-2770
Closed Access | Times Cited: 8
Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets
N Wang, Peng Sun, Qi-Qi Shen, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington’s disease
Andrea Moreu-Valls, Arnau Puig‐Davi, Saül Martínez‐Horta, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Closed Access | Times Cited: 1
Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
Rohan Gupta, Dia Advani, Divya Yadav, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6476-6529
Closed Access | Times Cited: 20
Personalized antisense oligonucleotides ‘for free, for life’ — the n-Lorem Foundation
Joseph G. Gleeson, C. Frank Bennett, Jeffrey B. Carroll, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1302-1303
Closed Access | Times Cited: 18
Mitochondrial dysfunction, oxidative stress, ER stress and mitochondria-ER crosstalk alterations in a chemical rat model of Huntington's disease: Potential benefits of bezafibrate
Morgana Brondani, Ana Cristina Roginski, Rafael Teixeira Ribeiro, et al.
Toxicology Letters (2023) Vol. 381, pp. 48-59
Closed Access | Times Cited: 17
Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target
Ya-Na Yang, Mao-Qing Zhang, Feng-Lin Yu, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115717-115717
Closed Access | Times Cited: 16
Oligodendrocyte pathology in Huntington’s disease: from mechanisms to therapeutics
Costanza Ferrari Bardile, Carola I. Radulescu, Mahmoud A. Pouladi
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 802-816
Closed Access | Times Cited: 16
Copper homeostasis and cuproptosis in health and disease
Yunuo Yang, Jiaxuan Wu, Lisheng Wang, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 7
Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases
Dong Guo, Zhihao Liu, Jinglin Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9947-9947
Open Access | Times Cited: 7
Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease
Marta Pengo, Ferdinando Squitieri
Genes (2024) Vol. 15, Iss. 6, pp. 807-807
Open Access | Times Cited: 6
Tailoring the pKa of Fluorescence Lifetime Imaging Probes to Visualize Aggrephagy and Resolve Its Microenvironmental Viscosity
Yu Wei, Xiaochen Gao, Jiabao Fang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 35, pp. 14160-14167
Closed Access | Times Cited: 6
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Asif Ahmad Bhat, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 10
Open Access | Times Cited: 6
Pridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip model
Sophie Lenoir, Romane A. Lahaye, Hélène Vitet, et al.
Neurobiology of Disease (2022) Vol. 173, pp. 105857-105857
Closed Access | Times Cited: 23
The evolution of comprehensive genetic analysis in neurology: Implications for precision medicine
Eirini Papadopoulou, Georgia Pepe, Spiridon Konitsiotis, et al.
Journal of the Neurological Sciences (2023) Vol. 447, pp. 120609-120609
Open Access | Times Cited: 15
Huntington’s Disease Drug Development: A Phase 3 Pipeline Analysis
Hannah J. Van de Roovaart, Nguyen Nguyen, Timothy D. Veenstra
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1513-1513
Open Access | Times Cited: 15
A vivid outline demonstrating the benefits of exosome-mediated drug delivery in CNS-associated disease environments
Rachayeeta Ray, Sougata Ghosh Chowdhury, Parimal Karmakar
Archives of Biochemistry and Biophysics (2024) Vol. 753, pp. 109906-109906
Closed Access | Times Cited: 5
Applications of Raman spectroscopy in the diagnosis and monitoring of neurodegenerative diseases
Chao Chen, Jinfeng Qi, Ying Li, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
High Levels of Mutant Huntingtin Protein in Tear Fluid From Huntington’s Disease Gene Expansion Carriers
Marlies Gijs, Nynke Jorna, Nicole A. Datson, et al.
Journal of Movement Disorders (2024) Vol. 17, Iss. 2, pp. 181-188
Open Access | Times Cited: 5
Huntington's disease: A clinical primer for acute and general physicians
Thomas H. Massey, Duncan McLauchlan
Clinical Medicine (2024) Vol. 24, Iss. 2, pp. 100200-100200
Open Access | Times Cited: 5
Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Hye Kyu Choi, Meizi Chen, Li Ling Goldston, et al.
Nano Convergence (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington’s Disease
Yousef Tizabi, Samia Bennani, Nacer El Kouhen, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1144-1144
Open Access | Times Cited: 5

Scroll to top